down arrow

Sequent Scien.

29
Strong Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE807F01027
  • NSEID: SEQUENT
  • BSEID: 512529
INR
136.75
4.65 (3.52%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 3.59 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Sequent Scien. Cash flow Statement
Figures in Rs cr
Consolidated Cash Flow Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-54.00
-137.00
52.00
145.00
94.00
58.00
Adjustment
144.00
220.00
93.00
83.00
91.00
84.00
Changes In working Capital
-45.00
-51.00
-89.00
-70.00
-58.00
-27.00
Cash Flow after changes in Working Capital
44.00
31.00
57.00
158.00
127.00
115.00
Cash Flow from Operating Activities
30.00
16.00
30.00
114.00
115.00
116.00
Cash Flow from Investing Activities
-5.00
-64.00
-94.00
9.00
-72.00
-67.00
Cash Flow from Financing Activities
-1.00
32.00
67.00
-138.00
-42.00
-20.00
Net Cash Inflow / Outflow
23.00
-15.00
3.00
-14.00
0.00
28.00
Opening Cash & Cash Equivalents
41.00
57.00
53.00
68.00
67.00
39.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
64.00
41.00
57.00
53.00
68.00
67.00
Compare Cash Flow Results of Sequent Scien.
Markets Mojo
Figures in Rs cr
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
-54.65
2399.36
-2,453.00
-102.28%
Adjustment
144.97
212.2
-68.00
-31.68%
Changes In working Capital
-45.67
20.42
-65.00
-323.65%
Cash Flow after changes in Working Capital
44.65
2631.98
-2,587.00
-98.30%
Cash Flow from Operating Activities
30.6
2152.45
-2,122.00
-98.58%
Cash Flow from Investing Activities
-5.92
-2080.52
2,075.00
99.72%
Cash Flow from Financing Activities
-1.44
5.27
-6.00
-127.32%
Net Cash Inflow / Outflow
23.24
77.19
-54.00
-69.89%
Opening Cash & Cash Equivalents
41.57
304.82
-263.00
-86.36%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
64.81
382.01
-318.00
-83.03%
Cash Flow - Snapshot (Consolidated) - Mar'24
stock-summary

YoY Growth in year ended Mar 2024 is 82.03% vs -45.07% in Mar 2023

Mar'24
Mar'23
Change(%)
Cash Flow from Operating Activities
30.60
16.81
82.03%